Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ephedrine add-on n-of-one trial in generalized myasthenia gravis
NL-OMON39601Phase 2Active, not recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of ephedrine in myasthenia gravis (MG) (2 arms), sponsored by Leiden University Medical Center. Primary endpoint: Primary efficacy endpoint. Started Oct 2014; status: active, not recruiting.
02
Drugs
ephedrine
03
Conditions
myasthenia gravis (MG)
Beyond the preview
Go deeper on NL-OMON39601.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON39601.